Quests

Choose a good quest.

Every ranked problem, in the existing rank order. Each card shows what the sources say just became possible, who is building, who funds it, and the gap between sourced demand and the named teams and capital on this site. Missing data stays missing.

The player half of this page follows Choose Good Quests. The essay does not supply a score, and this page does not add one. Problem rankings are unchanged. Method notes live on the methodology page.

Player card

Skills, domains, technologies, places, communities, networks, capital, time, and risk appetite. Technologies are enabling tags with a source, not problems. Stored in this browser. A share link or a downloaded image carries only the fields you select.

Skills
Domains
Technologies

Enabling tools, not problems. A technology matches only when a sourced company on the quest carries that tag.

Places
Communities you can reach (16)
Networks (207)

Showing 40 names. The list is the sourced set, not a search of the world.

Capital
Time
Risk appetite

/where

Saved in this browser only. Nothing is sent and nothing is written into the repository. See where this card fits

Site rank 1 · Health · welfare

Neglected tropical diseases

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

1.495 billion people required interventions in 2023, the figure in the WHO 2025 report.

What just became possible

not yet sourced

Companies working on this (0)

No sourced company is on file.

Open quest, not a real company

Acme Neglected tropical diseases Co. (open quest, not a real company)

Problem: Neglected tropical diseases. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Medicines alone may not be enough where water, sanitation and vector control lag. This is our inference. WHO Global report on neglected tropical diseases 2025

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 2,062 works Source
  • NIH RePORTER funding: 32,201,044 USD Source
  • OpenAlex company affiliations: 170 companies Source
  • ClinicalTrials.gov active trials: 11 active trials Source
  • ClinicalTrials.gov industry sponsors: 0 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 83 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 114,627 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
1,495,000,000 people requiring interventions against NTDs in 2023 (interventions-required)
WHO Global report on neglected tropical diseases 2025: an estimated 1.495 billion people required interventions against NTDs in 2023 · 2026-11-06
Headline scale
1,495,000,000 people requiring interventions against NTDs in 2023 (WHO Global report 2025). The live chart is the later GHO series and is not this headline. (improving)
WHO Global report on neglected tropical diseases 2025. Key facts: 1.495 billion people required interventions in 2023, 122 million fewer than in 2022. · 2026-11-06
Market size
4,000,000,000 USD — addressable diagnostics + therapeutics market at full coverage
The pharmaceutical industry’s multifaceted role in neglected tropical disease control (2026 review) · 2026-08-06
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
2,062 works
Query: neglected tropical diseases · 2026-11-10
NIH RePORTER funding
32,201,044 USD
Query: neglected tropical diseases (FY2026) · 2026-11-10
OpenAlex company affiliations
170 companies
Query: neglected tropical diseases · 2026-11-10
ClinicalTrials.gov active trials
11 active trials
Query: Neglected Tropical Diseases · 2026-11-10
ClinicalTrials.gov industry sponsors
0 industry sponsors
Query: Neglected Tropical Diseases · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
83 awards
Query: neglected tropical diseases · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
114,627 pageviews
Query: Neglected_tropical_diseases · 2026-11-10

Open the problem

Site rank 2 · Health · welfare

Hypertension control

Sourced demand is listed on this quest. 5 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

1.4 billion people have high blood pressure. The pills are cheap; only 23 percent have it controlled.

What just became possible

Opportunistically Detecting Signs of Hypertension on a Consumer Smartwatch

Nature · 2026-11-05 · peer-reviewed · tagged tractability

AI on photoplethysmography and accelerometry from a consumer smartwatch, with no cuff calibration, was validated prospectively in 196 participants against 24-hour ambulatory blood pressure: over seven days, sensitivity was 65.8% and specificity 90.0%, versus initial office blood pressure screening sensitivity 55.3% and specificity 90.0%. Over half of adults with hypertension are unaware of it.

Companies working on this (3)

Open quest, not a real company

Acme Hypertension control Co. (open quest, not a real company)

Problem: Hypertension control. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Medicines are not reliably on the shelf. WHO global report on hypertension, 2025

Demand numbers

  • Related deaths / yr: 6,800,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 68,834 works Source
  • NIH RePORTER funding: 1,497,563,493 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 2,255 active trials Source
  • ClinicalTrials.gov industry sponsors: 237 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 2,319 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 895,815 pageviews Source
  • Sourced companies on file: 3 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Hypertension control Co. (open quest, not a real company)

Problem: Hypertension control. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Readings are too noisy to diagnose and treat on. WHO HEARTS technical package

Demand numbers

  • Related deaths / yr: 6,800,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 68,834 works Source
  • NIH RePORTER funding: 1,497,563,493 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 2,255 active trials Source
  • ClinicalTrials.gov industry sponsors: 237 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 2,319 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 895,815 pageviews Source
  • Sourced companies on file: 3 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Hypertension control Co. (open quest, not a real company)

Problem: Hypertension control. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Pressure keeps rising because salt is built into the food supply. WHO, SHAKE the salt habit, 2026

Demand numbers

  • Related deaths / yr: 6,800,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 68,834 works Source
  • NIH RePORTER funding: 1,497,563,493 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 2,255 active trials Source
  • ClinicalTrials.gov industry sponsors: 237 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 2,319 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 895,815 pageviews Source
  • Sourced companies on file: 3 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 5 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
1,400,000,000 adults aged 30-79 living with hypertension (prevalence)
WHO Global report on hypertension 2025 · 2026-08-27
Headline scale
1,400,000,000 adults aged 30-79 with hypertension (worsening)
WHO Hypertension fact sheet, 2025 · 2026-08-27
Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
68,834 works
Query: hypertension · 2026-11-10
NIH RePORTER funding
1,497,563,493 USD
Query: hypertension (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
2,255 active trials
Query: Hypertension · 2026-11-10
ClinicalTrials.gov industry sponsors
237 industry sponsors
Query: Hypertension · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
2,319 awards
Query: hypertension · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
895,815 pageviews
Query: Hypertension · 2026-11-10

Open the problem

Site rank 3 · Health · welfare

COPD and chronic respiratory disease

Sourced demand is listed on this quest. 9 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

The third leading cause of death worldwide, and one of the least funded.

What just became possible

not yet sourced

Newest sourced finding

This row is tagged scale, so it is not shown as a new capability.

Companies working on this (5)

Open quest, not a real company

Acme COPD and chronic respiratory disease Co. (open quest, not a real company)

Problem: COPD and chronic respiratory disease. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: No treatment cures COPD. WHO COPD fact sheet (opened 2026-11-11)

Demand numbers

  • Related deaths / yr: 3,500,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 11,541 works Source
  • NIH RePORTER funding: 286,637,697 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 980 active trials Source
  • ClinicalTrials.gov industry sponsors: 134 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 325 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 1,258,182 pageviews Source
  • Sourced companies on file: 5 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: Biotech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 9 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
213,390,000 prevalent cases of COPD (2021) (prevalence)
Global Burden of Disease Study 2021, COPD burden in 204 countries · 2026-09-11
Market size
19,800,000,000 USD / year, global COPD drug market (2024), market-research estimate
Data Bridge Market Research, COPD drug market 2024 · 2026-09-11
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
11,541 works
Query: chronic obstructive pulmonary disease · 2026-11-10
NIH RePORTER funding
286,637,697 USD
Query: chronic obstructive pulmonary disease (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
980 active trials
Query: Pulmonary Disease, Chronic Obstructive · 2026-11-10
ClinicalTrials.gov industry sponsors
134 industry sponsors
Query: Pulmonary Disease, Chronic Obstructive · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
325 awards
Query: chronic obstructive pulmonary disease · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
1,258,182 pageviews
Query: Chronic_obstructive_pulmonary_disease · 2026-11-10

Open the problem

Site rank 4 · Education · progress

Pedagogy at scale

Sourced demand is listed on this quest. 8 named team rows on this site. 6 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

One-on-one tutoring works far better than classrooms. AI may make it affordable for every child.

What just became possible

Preprimary education laws and women's gender attitudes, empowerment and reproductive autonomy in 117 low- and middle-income countries

Nature Human Behaviour · 2026-11-04 · peer-reviewed · tagged tractability

Across 495 surveys covering nearly 6.7 million women in 117 low- and middle-income countries, eligibility under preprimary education legislation was associated with higher female primary enrolment (+1.21 pp) and completion (+0.75 pp), greater ever use of contraception (+2.96 pp), and lower adolescent childbearing (-2.41 pp) and child marriage (-0.43 pp).

Companies working on this (5)

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 8 named team rows on this site. 6 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
1,500,000,000 children undereducated (prevalence)
UNESCO Global Education Monitoring Report · 2026-04-24
Headline scale
0.7 share of 10-year-olds in low/middle-income countries who cannot read a simple text (worsening)
World Bank "learning poverty": ~57% pre-COVID, ~70% after pandemic school closures. · 2026-06-09
Market size
6,000,000,000,000 USD / year
global education spend (UNESCO Global Education Monitoring Report); EdTech slice ~$400B and growing · 2026-05-09
Annual capital flow
3,000,000,000 USD/yr (falling)
HolonIQ — global edtech venture funding · 2025-01-31
Adult literacy rate
87.74 %
Query: SE.ADT.LITR.ZS · 2026-11-10
OpenAlex works, last 12 months
14,877 works
Query: tutoring · 2026-11-10
NIH RePORTER funding
703,568,885 USD
Query: tutoring (FY2026) · 2026-11-10
OpenAlex company affiliations
147 companies
Query: tutoring · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
30 documents
Query: tutoring · 2026-11-10
USAspending awards
691 awards
Query: tutoring · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
973,457 pageviews
Query: Education · 2026-11-10

Open the problem

Site rank 5 · Social · emerging

Loneliness & social isolation

Sourced demand is listed on this quest. 6 named team rows on this site. 1 named capital row on this site. Named capital rows are fewer than named team rows.

Open

The US Surgeon General called it an epidemic. Mortality effect equivalent to smoking 15 cigarettes a day.

What just became possible

not yet sourced

Newest sourced finding

This row is tagged scale, so it is not shown as a new capability.

Companies working on this (4)

Open quest, not a real company

Acme Loneliness & social isolation Co. (open quest, not a real company)

Problem: Loneliness & social isolation. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: The binding constraint is repeated time with the same people. Adults do not get the 50 to 200 hours a friendship takes unless a setting supplies them. University of Kansas, on Hall, Journal of Social and Personal Relationships, 2018

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 13,095 works Source
  • NIH RePORTER funding: 139,996,446 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 122 active trials Source
  • ClinicalTrials.gov industry sponsors: 2 industry sponsors Source
  • Federal Register documents: 19 documents Source
  • USAspending awards: 240 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 188,545 pageviews Source
  • Sourced companies on file: 4 companies
  • Sourced founders: 0 founders
  • Sourced funders: 1 funders
  • Annual capital: 300,000,000 USD/yr Source

Founder fit

  • Skills: Design
  • Domains: Social
  • Technologies: AI
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Loneliness & social isolation Co. (open quest, not a real company)

Problem: Loneliness & social isolation. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: For people who are already lonely, more contact is not enough. The interventions that worked best changed how lonely people think about others. Masi, Chen, Hawkley and Cacioppo, A Meta-Analysis of Interventions to Reduce Loneliness, Pers Soc Psychol Rev, 2011

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 13,095 works Source
  • NIH RePORTER funding: 139,996,446 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 122 active trials Source
  • ClinicalTrials.gov industry sponsors: 2 industry sponsors Source
  • Federal Register documents: 19 documents Source
  • USAspending awards: 240 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 188,545 pageviews Source
  • Sourced companies on file: 4 companies
  • Sourced founders: 0 founders
  • Sourced funders: 1 funders
  • Annual capital: 300,000,000 USD/yr Source

Founder fit

  • Skills: Design
  • Domains: Social
  • Technologies: AI
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Loneliness & social isolation Co. (open quest, not a real company)

Problem: Loneliness & social isolation. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: The settings that put people near each other every day, such as shared housing, have not held up as businesses, so the supply of them stays small. Bisnow, Co-living firm Common to shutter after aggressive expansion ends in bankruptcy, 2024-06-03

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 13,095 works Source
  • NIH RePORTER funding: 139,996,446 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 122 active trials Source
  • ClinicalTrials.gov industry sponsors: 2 industry sponsors Source
  • Federal Register documents: 19 documents Source
  • USAspending awards: 240 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 188,545 pageviews Source
  • Sourced companies on file: 4 companies
  • Sourced founders: 0 founders
  • Sourced funders: 1 funders
  • Annual capital: 300,000,000 USD/yr Source

Founder fit

  • Skills: Design
  • Domains: Social
  • Technologies: AI
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 6 named team rows on this site. 1 named capital row on this site. Named capital rows are fewer than named team rows.

Humans affected
1,500,000,000 adults reporting measurable loneliness (prevalence)
US Surgeon General 2023 advisory + global WHO data · 2026-04-24
Headline scale
0.24 share of adults reporting significant loneliness (global) (worsening)
Meta-Gallup global survey (2023): ~24% of adults aged 15+ felt very or fairly lonely. The WHO declared loneliness a global health priority. · 2026-06-09
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
13,095 works
Query: loneliness · 2026-11-10
NIH RePORTER funding
139,996,446 USD
Query: loneliness (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
122 active trials
Query: Loneliness · 2026-11-10
ClinicalTrials.gov industry sponsors
2 industry sponsors
Query: Loneliness · 2026-11-10
Federal Register documents
19 documents
Query: loneliness · 2026-11-10
USAspending awards
240 awards
Query: loneliness · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
188,545 pageviews
Query: Social_isolation · 2026-11-10

Open the problem

Site rank 6 · Biosecurity · x-risk

Biosecurity & pandemic preparedness

Sourced demand is listed on this quest. 7 named team rows on this site. 3 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Stop the next pandemic, natural or engineered, before it spreads.

What just became possible

Companies working on this (4)

Open quest, not a real company

Acme Biosecurity & pandemic preparedness Co. (open quest, not a real company)

Problem: Biosecurity & pandemic preparedness. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Preparedness has an estimated funding gap, and overall aid is now falling. WHO, statement on a financial intermediary fund for pandemic preparedness, 19 April 2022

Demand numbers

  • Related deaths / yr: 8,800,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 4,315 works Source
  • NIH RePORTER funding: 248,311,579 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 41 documents Source
  • USAspending awards: 149 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 30,945 pageviews Source
  • Sourced companies on file: 4 companies
  • Sourced founders: 0 founders
  • Sourced funders: 3 funders
  • Annual capital: 4,000,000,000 USD/yr Source

Founder fit

  • Skills: Biology, Policy, Research
  • Domains: Biosecurity
  • Technologies: Biotech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 7 named team rows on this site. 3 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
8,100,000,000 humans potentially exposed to a pandemic tail, not people currently ill (population)
80,000 Hours biosecurity profile · 2026-04-24
Market size
100,000,000,000 USD / year
projected global biosecurity + pandemic-prep market (vaccines, surveillance, broad-spectrum countermeasures, PPE) at full deployment · 2026-05-09
Annual capital flow
4,000,000,000 USD/yr (falling)
US ASPR/BARDA budgets + Open Philanthropy biosecurity grants (estimate) · 2025-10-01
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
4,315 works
Query: biosecurity · 2026-11-10
NIH RePORTER funding
248,311,579 USD
Query: pandemic preparedness (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
41 documents
Query: biosecurity · 2026-11-10
USAspending awards
149 awards
Query: pandemic preparedness · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
30,945 pageviews
Query: Biosecurity · 2026-11-10

Open the problem

Site rank 7 · Poverty · hard-tech

Low-cost housing & construction

Sourced demand is listed on this quest. 6 named team rows on this site. 5 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Too few homes get built, so homes cost too much.

What just became possible

Companies working on this (5)

Open quest, not a real company

Acme Low-cost housing & construction Co. (open quest, not a real company)

Problem: Low-cost housing & construction. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: In high-cost cities, rules on what may be built keep housing supply below demand. Glaeser and Gyourko, The Economic Implications of Housing Supply, Journal of Economic Perspectives 2018

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 4,478 works Source
  • NIH RePORTER funding: 4,710,958 USD Source
  • OpenAlex company affiliations: 53 companies Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 374 documents Source
  • USAspending awards: 28 awards Source
  • SEC EDGAR Form D filings: 374 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 91,028 pageviews Source
  • Sourced companies on file: 5 companies
  • Sourced founders: 0 founders
  • Sourced funders: 5 funders
  • Annual capital: 10,000,000,000 USD/yr Source

Founder fit

  • Skills: Policy, Sales
  • Domains: Poverty
  • Technologies: Robotics
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Low-cost housing & construction Co. (open quest, not a real company)

Problem: Low-cost housing & construction. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Building homes has not become more productive, so cost does not fall the way it does for manufactured goods. Goolsbee and Syverson, The Strange and Awful Path of Productivity in the U.S. Construction Sector, NBER w30845

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 4,478 works Source
  • NIH RePORTER funding: 4,710,958 USD Source
  • OpenAlex company affiliations: 53 companies Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 374 documents Source
  • USAspending awards: 28 awards Source
  • SEC EDGAR Form D filings: 374 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 91,028 pageviews Source
  • Sourced companies on file: 5 companies
  • Sourced founders: 0 founders
  • Sourced funders: 5 funders
  • Annual capital: 10,000,000,000 USD/yr Source

Founder fit

  • Skills: Policy, Sales
  • Domains: Poverty
  • Technologies: Robotics
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Who funds it

The gap

Sourced demand is listed on this quest. 6 named team rows on this site. 5 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
3,400,000,000 people lacking secure, safe and adequate housing (upper estimate) (prevalence)
UN-Habitat, World Cities Report 2026 ("up to 3.4 billion") · 2026-11-13
Headline scale
3,400,000,000 people lacking secure, safe and adequate housing (upper estimate) (worsening)
UN-Habitat, World Cities Report 2026: up to 3.4 billion people lack access to secure, safe, and adequate housing, including more than 1 billion in informal settlements and slums. · 2026-11-13
Market size
13,000,000,000,000 USD / year
global construction market (Oxford Economics, McKinsey Global Institute) · 2026-05-09
Annual capital flow
10,000,000,000 USD/yr (falling)
Construction & property tech venture funding (CREtech / industry trackers, estimate) · 2025-01-31
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
4,478 works
Query: housing affordability · 2026-11-10
NIH RePORTER funding
4,710,958 USD
Query: housing affordability (FY2026) · 2026-11-10
OpenAlex company affiliations
53 companies
Query: housing affordability · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
374 documents
Query: housing affordability · 2026-11-10
USAspending awards
28 awards
Query: housing affordability · 2026-11-10
SEC EDGAR Form D filings
374 filings
Query: "Construction" · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
91,028 pageviews
Query: Affordable_housing · 2026-11-10

Open the problem

Site rank 8 · Social · emerging

Fertility decline & demographic stagnation

Sourced demand is listed on this quest. 6 named team rows on this site. 1 named capital row on this site. Named capital rows are fewer than named team rows.

Open

Every developed country now has fewer births than it needs to keep its population steady.

What just became possible

Bureaucratic incentives shaped effectiveness of the one-child policy in China

Nature · 2026-11-11 · peer-reviewed · tagged tractability

China's one vote veto policy, which strictly prohibited career advancement for adherence failure, explains nearly half of China's total fertility rate decline during the 1990s and drove fertility below the replacement rate. The findings suggest that stronger bureaucratic enforcement made a greater contribution to low fertility than past research found.

Companies working on this (4)

Open quest, not a real company

Acme Fertility decline & demographic stagnation Co. (open quest, not a real company)

Problem: Fertility decline & demographic stagnation. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: About four in ten people surveyed say money limits the family size they want. UNFPA, State of World Population 2025: The Real Fertility Crisis

Demand numbers

  • Related deaths / yr: not yet sourced
  • Total fertility rate: 2.188 births/woman Source
  • OpenAlex works, last 12 months: 4,432 works Source
  • NIH RePORTER funding: 313,438,188 USD Source
  • OpenAlex company affiliations: 132 companies Source
  • ClinicalTrials.gov active trials: 521 active trials Source
  • ClinicalTrials.gov industry sponsors: 51 industry sponsors Source
  • Federal Register documents: 53 documents Source
  • USAspending awards: 819 awards Source
  • SEC EDGAR Form D filings: 5 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 110,844 pageviews Source
  • Sourced companies on file: 4 companies
  • Sourced founders: 0 founders
  • Sourced funders: 1 funders
  • Annual capital: 1,000,000,000 USD/yr Source

Founder fit

  • Skills: Design
  • Domains: Social
  • Technologies: Biotech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Fertility decline & demographic stagnation Co. (open quest, not a real company)

Problem: Fertility decline & demographic stagnation. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: People cannot have children at the age they would prefer, and births move later. UNFPA, State of World Population 2025: The Real Fertility Crisis

Demand numbers

  • Related deaths / yr: not yet sourced
  • Total fertility rate: 2.188 births/woman Source
  • OpenAlex works, last 12 months: 4,432 works Source
  • NIH RePORTER funding: 313,438,188 USD Source
  • OpenAlex company affiliations: 132 companies Source
  • ClinicalTrials.gov active trials: 521 active trials Source
  • ClinicalTrials.gov industry sponsors: 51 industry sponsors Source
  • Federal Register documents: 53 documents Source
  • USAspending awards: 819 awards Source
  • SEC EDGAR Form D filings: 5 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 110,844 pageviews Source
  • Sourced companies on file: 4 companies
  • Sourced founders: 0 founders
  • Sourced funders: 1 funders
  • Annual capital: 1,000,000,000 USD/yr Source

Founder fit

  • Skills: Design
  • Domains: Social
  • Technologies: Biotech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Who funds it

The gap

Sourced demand is listed on this quest. 6 named team rows on this site. 1 named capital row on this site. Named capital rows are fewer than named team rows.

Humans affected
6,000,000,000 humans in countries below replacement (population)
UN World Population Prospects · 2026-04-24
Market size
50,000,000,000 USD / year
addressable: fertility tech, IVF, childcare, ART, family-formation services (Frost & Sullivan); demographic-collapse cost is GDP-scale but indirect · 2026-05-09
Annual capital flow
1,000,000,000 USD/yr (flat)
Fertility-tech / femtech venture tracking (PitchBook, FemHealth Insights; estimate) · 2025-06-30
Expert prior
not yet sourced
Total fertility rate
2.188 births/woman
Query: SP.DYN.TFRT.IN · 2026-11-10
OpenAlex works, last 12 months
4,432 works
Query: fertility decline · 2026-11-10
NIH RePORTER funding
313,438,188 USD
Query: infertility (FY2026) · 2026-11-10
OpenAlex company affiliations
132 companies
Query: fertility decline · 2026-11-10
ClinicalTrials.gov active trials
521 active trials
Query: Infertility · 2026-11-10
ClinicalTrials.gov industry sponsors
51 industry sponsors
Query: Infertility · 2026-11-10
Federal Register documents
53 documents
Query: fertility · 2026-11-10
USAspending awards
819 awards
Query: fertility · 2026-11-10
SEC EDGAR Form D filings
5 filings
Query: fertility · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
110,844 pageviews
Query: Sub-replacement_fertility · 2026-11-10

Open the problem

Site rank 9 · Longevity · hard-tech

Longevity & aging

Sourced demand is listed on this quest. 14 named team rows on this site. 11 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Aging drives most disease. Slow it and most diseases recede.

What just became possible

Caloric restriction modulates genome-wide somatic mutation in mice

Cell · 2026-09-09 · peer-reviewed · tagged tractability

30% calorie restriction in 19-month-old male mice reduced somatic substitution and indel burdens, but two restriction regimens with different lifespan effects cut mutations similarly, suggesting mutation burden is not the sole or rate-limiting driver of lifespan.

A natural experiment on the effect of herpes zoster vaccination on dementia

Nature · 2025-04-02 · peer-reviewed · tagged tractability

In a Wales natural experiment, the live-attenuated vaccine Zostavax was associated with 3.5 percentage points fewer new dementia diagnoses over 7 years (95% CI 0.6-7.1), a 20.0% relative reduction (95% CI 6.5-33.4). The regression weights people primarily aged 79 to 80. This is one study’s estimate, not proof the vaccine prevents dementia in every population.

Companies working on this (8)

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 14 named team rows on this site. 11 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
8,100,000,000 humans (everyone ages; a population stock, not a disease prevalence) (population)
UN Population Division · 2026-04-24
Market size
4,000,000,000,000 USD / year
global healthcare spend for ages 65+ (OECD Health Statistics); standalone longevity-tech market projected $44B → $600B by 2035 · 2026-05-09
Annual capital flow
8,000,000,000 USD/yr (flat)
NIA budget (~$4.4B) + longevity-biotech venture funding (Longevity.Technology tracking) · 2025-09-30
Life expectancy at birth
73.3 years
Query: WHOSIS_000001 · 2026-11-10
OpenAlex works, last 12 months
19,342 works
Query: longevity|healthspan · 2026-11-10
NIH RePORTER funding
438,407,873 USD
Query: aging longevity (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
1,066 active trials
Query: Aging · 2026-11-10
ClinicalTrials.gov industry sponsors
92 industry sponsors
Query: Aging · 2026-11-10
Federal Register documents
77 documents
Query: longevity · 2026-11-10
USAspending awards
429 awards
Query: aging research · 2026-11-10
SEC EDGAR Form D filings
35 filings
Query: longevity · 2026-11-10
openFDA current drug shortages
8 distinct drugs
Query: Oncology · 2026-11-10
Wikipedia pageviews (attention, not demand)
166,553 pageviews
Query: Longevity · 2026-11-10

Open the problem

Site rank 10 · Poverty · welfare

Extreme poverty

Sourced demand is listed on this quest. 6 named team rows on this site. 3 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Lift the 811 million people living on less than $3 a day into stable prosperity.

What just became possible

Companies working on this (0)

No sourced company is on file.

Open quest, not a real company

Acme Extreme poverty Co. (open quest, not a real company)

Problem: Extreme poverty. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Extreme poverty is concentrating in countries with conflict or instability, where incomes are falling. World Bank, fragile and conflict-affected situations press release, 27 June 2025

Demand numbers

  • Related deaths / yr: not yet sourced
  • Extreme poverty headcount ratio: 10.1 % of population Source
  • OpenAlex works, last 12 months: 1,487 works Source
  • NIH RePORTER funding: 25,351,117 USD Source
  • OpenAlex company affiliations: 47 companies Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 237 documents Source
  • USAspending awards: 6,806 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 128,255 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 3 founders
  • Sourced funders: 0 funders
  • Annual capital: 212,000,000,000 USD/yr Source

Founder fit

  • Skills: Policy, Sales
  • Domains: Poverty
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Extreme poverty Co. (open quest, not a real company)

Problem: Extreme poverty. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Income growth per person in the poorest countries is too slow to end extreme poverty in this generation. World Bank, Poverty, Prosperity, and Planet Report 2024 press release

Demand numbers

  • Related deaths / yr: not yet sourced
  • Extreme poverty headcount ratio: 10.1 % of population Source
  • OpenAlex works, last 12 months: 1,487 works Source
  • NIH RePORTER funding: 25,351,117 USD Source
  • OpenAlex company affiliations: 47 companies Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 237 documents Source
  • USAspending awards: 6,806 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 128,255 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 3 founders
  • Sourced funders: 0 funders
  • Annual capital: 212,000,000,000 USD/yr Source

Founder fit

  • Skills: Policy, Sales
  • Domains: Poverty
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Extreme poverty Co. (open quest, not a real company)

Problem: Extreme poverty. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Direct support works, but it does not reach most of the people who need it. World Bank, State of Social Protection Report 2025

Demand numbers

  • Related deaths / yr: not yet sourced
  • Extreme poverty headcount ratio: 10.1 % of population Source
  • OpenAlex works, last 12 months: 1,487 works Source
  • NIH RePORTER funding: 25,351,117 USD Source
  • OpenAlex company affiliations: 47 companies Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 237 documents Source
  • USAspending awards: 6,806 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 128,255 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 3 founders
  • Sourced funders: 0 funders
  • Annual capital: 212,000,000,000 USD/yr Source

Founder fit

  • Skills: Policy, Sales
  • Domains: Poverty
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 6 named team rows on this site. 3 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
811,000,000 people living below $3 a day (prevalence)
World Bank, poverty overview: 811 million people in extreme poverty, on less than $3 per day · 2026-11-13
Market size
70,000,000,000 USD / year
World Bank, Poverty, Prosperity, and Planet Report 2024 — total annual income shortfall to close the $2.15/day poverty gap for ~700M people, ~$100/person/year · 2026-08-20
Annual capital flow
212,000,000,000 USD/yr (falling)
OECD DAC — official development assistance (2024 preliminary) · 2025-04-15
Extreme poverty headcount ratio
10.1 % of population
Query: SI.POV.DDAY · 2026-11-10
OpenAlex works, last 12 months
1,487 works
Query: extreme poverty · 2026-11-10
NIH RePORTER funding
25,351,117 USD
Query: extreme poverty (FY2026) · 2026-11-10
OpenAlex company affiliations
47 companies
Query: extreme poverty · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
237 documents
Query: poverty · 2026-11-10
USAspending awards
6,806 awards
Query: poverty · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
128,255 pageviews
Query: Extreme_poverty · 2026-11-10

Open the problem

Site rank 11 · Health · welfare

Newborn survival

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

2.3 million babies die in their first month of life every year, mostly from causes medicine already knows how to prevent.

What just became possible

Nectin-4 mediates rubella virus entry in airway and placental cells

Nature · 2026-11-04 · peer-reviewed · tagged tractability

Nectin-4 is identified as a functional rubella virus entry receptor in airway and placental cells, shared with measles virus; Nectin-4 blockade significantly inhibited viral entry in human placental organoid models of transplacental infection.

RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants: A Systematic Review and Meta-Analysis

JAMA Pediatrics · 2026-11-01 · peer-reviewed · tagged tractability

In 7 real-world studies of 7112 infants from Argentina, the UK, and the US, maternal RSVpreF vaccination was 82% effective against RSV lower respiratory tract infection hospitalization from birth to age 3 months and 78% from birth to 6 months, when mothers were vaccinated 14 days or more before delivery.

Clostridium perfringens Delta toxin targets CD9 to drive NEC and brain injury

Nature · 2026-10-28 · peer-reviewed · tagged tractability

Delta-toxin-positive Clostridium perfringens was found in severe and fatal cases of necrotizing enterocolitis, a CRISPR screen identified CD9 as the toxin's receptor, and a neutralizing anti-Delta toxin monoclonal antibody protected mice against disease progression.

Companies working on this (0)

No sourced company is on file.

Open quest, not a real company

Acme Newborn survival Co. (open quest, not a real company)

Problem: Newborn survival. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Care around the hour of birth is not good enough to prevent early deaths. WHO newborn mortality fact sheet (opened 2026-11-11)

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 8,363 works Source
  • NIH RePORTER funding: 345,345,337 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 1,159 active trials Source
  • ClinicalTrials.gov industry sponsors: 94 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 49 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 127,349 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
2,300,000 newborn deaths per year (an annual flow, not people living with a condition) (annual-deaths)
UN Inter-agency Group for Child Mortality Estimation (UNICEF/WHO) · 2026-04-24
Headline scale
2,300,000 newborn deaths per year (improving)
UN Inter-agency Group for Child Mortality Estimation (UNICEF/WHO) · 2026-08-06
Market size
60,000,000 USD — CGD-estimated funding gap for a single rapid neonatal sepsis diagnostic (does not include oxygen/pulse-oximetry infrastructure, which is unquantified)
Center for Global Development — NeoTest: Accelerating Neonatal Sepsis Diagnostics · 2026-08-06
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
8,363 works
Query: neonatal mortality · 2026-11-10
NIH RePORTER funding
345,345,337 USD
Query: neonatal mortality (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
1,159 active trials
Query: Infant, Newborn · 2026-11-10
ClinicalTrials.gov industry sponsors
94 industry sponsors
Query: Infant, Newborn · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
49 awards
Query: neonatal mortality · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
127,349 pageviews
Query: Infant_mortality · 2026-11-10

Open the problem

Site rank 12 · Health · welfare

AI clinical care

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

WHO: about 4.6 billion people were not fully covered by essential health services in 2023.

What just became possible

not yet sourced

Companies working on this (1)

Who is building

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
4,600,000,000 people not fully covered by essential health services in 2023. WHO says about 4.6 billion. Not a count of patients in the Utah pilot. (population)
WHO universal health coverage fact sheet, 5 December 2025: in 2023, about 4.6 billion people were not fully covered by essential health services. · 2026-11-20
Headline scale
not yet sourced
Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
OpenAlex works, last 12 months
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
NIH RePORTER funding
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
USAspending awards
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
Wikipedia pageviews (attention, not demand)
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20

Open the problem

Site rank 13 · Energy · hard-tech

Energy abundance

Sourced demand is listed on this quest. 38 named team rows on this site. 16 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Clean, cheap power on demand, everywhere.

What just became possible

Companies working on this (34)

Open quest, not a real company

Acme Energy abundance Co. (open quest, not a real company)

Problem: Energy abundance. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Cheap clean generation is stranded because grid connection and wires lag years behind. ACEG and Grid Strategies, Fewer New Miles 2025

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 16,974 works Source
  • NIH RePORTER funding: 0 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 125 documents Source
  • USAspending awards: 338 awards Source
  • SEC EDGAR Form D filings: 490 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 543,117 pageviews Source
  • Sourced companies on file: 34 companies
  • Sourced founders: 3 founders
  • Sourced funders: 13 funders
  • Annual capital: 2,200,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Sales
  • Domains: Energy
  • Technologies: Energy tech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Energy abundance Co. (open quest, not a real company)

Problem: Energy abundance. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Clean power is cheap when the sun shines; firm power around the clock is not solved. BNEF: battery storage costs hit record lows

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 16,974 works Source
  • NIH RePORTER funding: 0 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 125 documents Source
  • USAspending awards: 338 awards Source
  • SEC EDGAR Form D filings: 490 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 543,117 pageviews Source
  • Sourced companies on file: 34 companies
  • Sourced founders: 3 founders
  • Sourced funders: 13 funders
  • Annual capital: 2,200,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Sales
  • Domains: Energy
  • Technologies: Energy tech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Energy abundance Co. (open quest, not a real company)

Problem: Energy abundance. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Four-hour storage is cheap; storage for multi-day and seasonal gaps is unproven at scale. Energy-Storage.news: turnkey prices by region and duration

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 16,974 works Source
  • NIH RePORTER funding: 0 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 125 documents Source
  • USAspending awards: 338 awards Source
  • SEC EDGAR Form D filings: 490 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 543,117 pageviews Source
  • Sourced companies on file: 34 companies
  • Sourced founders: 3 founders
  • Sourced funders: 13 funders
  • Annual capital: 2,200,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Sales
  • Domains: Energy
  • Technologies: Energy tech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 38 named team rows on this site. 16 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
8,100,000,000 humans (population exposure, not people without electricity) (population)
IEA World Energy Outlook · 2026-04-24
Headline scale
750,000,000 people without electricity access (improving)
IEA / World Bank SDG7 tracking: people without electricity access · 2026-06-09
Annual capital flow
2,200,000,000,000 USD/yr (rising)
IEA — World Energy Investment 2025 (clean energy investment) · 2025-06-01
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
16,974 works
Query: decarbonization · 2026-11-10
NIH RePORTER funding
0 USD
Query: decarbonization (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
125 documents
Query: geothermal · 2026-11-10
USAspending awards
338 awards
Query: geothermal · 2026-11-10
SEC EDGAR Form D filings
490 filings
Query: "Other Energy" · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
543,117 pageviews
Query: Renewable_energy · 2026-11-10

Open the problem

Site rank 14 · Health · welfare

Infectious disease (malaria, TB, HIV)

Sourced demand is listed on this quest. 10 named team rows on this site. 7 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Malaria, TB and HIV still kill millions, and the cures are cheap.

What just became possible

Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial

The Lancet Infectious Diseases · 2026-11-06 · trial-result · tagged tractability

In the main part, 220 children across Burkina Faso, Mali, Cote d'Ivoire, Gabon, and DR Congo had PCR-corrected cure on day 29 of 97 of 98 (99%) with ganaplacide plus lumefantrine versus 98 of 99 (99%) with artemether-lumefantrine, a non-inferior result, and vomiting was 29% versus 11%. Ganaplacide is a new non-artemisinin antimalarial class, and a phase 3 trial followed (NCT05842954).

Nectin-4 mediates rubella virus entry in airway and placental cells

Nature · 2026-11-04 · peer-reviewed · tagged tractability

Nectin-4 is identified as a functional rubella virus entry receptor in airway and placental cells, shared with measles virus; Nectin-4 blockade significantly inhibited viral entry in human placental organoid models of transplacental infection.

RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants: A Systematic Review and Meta-Analysis

JAMA Pediatrics · 2026-11-01 · peer-reviewed · tagged tractability

In 7 real-world studies of 7112 infants from Argentina, the UK, and the US, maternal RSVpreF vaccination was 82% effective against RSV lower respiratory tract infection hospitalization from birth to age 3 months and 78% from birth to 6 months, when mothers were vaccinated 14 days or more before delivery.

Companies working on this (5)

Who is building

Who funds it

The gap

Sourced demand is listed on this quest. 10 named team rows on this site. 7 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
2,500,000,000 humans at risk of at least one of malaria, TB, or HIV (exposure, not prevalent cases) (at-risk)
WHO Global Burden of Disease · 2026-04-24
Market size
200,000,000,000 USD / year
global infectious-disease therapeutics + vaccines + diagnostics + delivery (WHO + IFPMA estimates) · 2026-05-09
Estimated malaria deaths
609,930 deaths/yr
Query: MALARIA_EST_DEATHS · 2026-11-10
OpenAlex works, last 12 months
36,308 works
Query: malaria|tuberculosis · 2026-11-10
NIH RePORTER funding
3,997,759,952 USD
Query: infectious disease (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
2,055 active trials
Query: malaria OR tuberculosis OR HIV · 2026-11-10
ClinicalTrials.gov industry sponsors
121 industry sponsors
Query: malaria OR tuberculosis OR HIV · 2026-11-10
Federal Register documents
58 documents
Query: tuberculosis · 2026-11-10
USAspending awards
1,523 awards
Query: malaria · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
7 distinct drugs
Query: Anti-Infective · 2026-11-10
Wikipedia pageviews (attention, not demand)
97,851 pageviews
Query: Infectious_disease · 2026-11-10

Open the problem

Site rank 15 · Climate · welfare

Climate change

Sourced demand is listed on this quest. 9 named team rows on this site. 6 named capital rows on this site. Named capital rows are fewer than named team rows.

Open

Decarbonize the global economy fast enough to limit warming, while keeping energy cheap and abundant.

What just became possible

Companies working on this (0)

No sourced company is on file.

Open quest, not a real company

Acme Climate change Co. (open quest, not a real company)

Problem: Climate change. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Emissions rise where energy demand is growing fastest, because clean build there has not yet outpaced demand. IEA, Global Energy Review 2025, CO2 emissions

Demand numbers

  • Related deaths / yr: not yet sourced
  • Annual CO₂ emissions: 38,598,580,000 t Source
  • OpenAlex works, last 12 months: 33,386 works Source
  • NIH RePORTER funding: 165,123,745 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 38 documents Source
  • USAspending awards: 362 awards Source
  • SEC EDGAR Form D filings: 210 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 167,337 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 6 founders
  • Sourced funders: 0 funders
  • Annual capital: 1,500,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Policy
  • Domains: Climate
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Climate change Co. (open quest, not a real company)

Problem: Climate change. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Clean projects in poorer countries pay more for capital and receive little of the investment. IEA, World Energy Investment 2025, executive summary

Demand numbers

  • Related deaths / yr: not yet sourced
  • Annual CO₂ emissions: 38,598,580,000 t Source
  • OpenAlex works, last 12 months: 33,386 works Source
  • NIH RePORTER funding: 165,123,745 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 38 documents Source
  • USAspending awards: 362 awards Source
  • SEC EDGAR Form D filings: 210 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 167,337 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 6 founders
  • Sourced funders: 0 funders
  • Annual capital: 1,500,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Policy
  • Domains: Climate
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Climate change Co. (open quest, not a real company)

Problem: Climate change. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Announced near-zero steel and cement capacity for 2030 is about a tenth of what a net-zero pathway needs. The IEA names cost as the main barrier. IEA, Demand and Supply Measures for the Steel and Cement Transition, executive summary

Demand numbers

  • Related deaths / yr: not yet sourced
  • Annual CO₂ emissions: 38,598,580,000 t Source
  • OpenAlex works, last 12 months: 33,386 works Source
  • NIH RePORTER funding: 165,123,745 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 38 documents Source
  • USAspending awards: 362 awards Source
  • SEC EDGAR Form D filings: 210 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 167,337 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 6 founders
  • Sourced funders: 0 funders
  • Annual capital: 1,500,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Policy
  • Domains: Climate
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Climate change Co. (open quest, not a real company)

Problem: Climate change. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: National policies and targets do not add up to the stated temperature goals. Climate Action Tracker, emissions pathways, updated 13 November 2025

Demand numbers

  • Related deaths / yr: not yet sourced
  • Annual CO₂ emissions: 38,598,580,000 t Source
  • OpenAlex works, last 12 months: 33,386 works Source
  • NIH RePORTER funding: 165,123,745 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 38 documents Source
  • USAspending awards: 362 awards Source
  • SEC EDGAR Form D filings: 210 filings Source
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 167,337 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 6 founders
  • Sourced funders: 0 funders
  • Annual capital: 1,500,000,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Policy
  • Domains: Climate
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 9 named team rows on this site. 6 named capital rows on this site. Named capital rows are fewer than named team rows.

Humans affected
8,200,000,000 humans (global exposure to climate impacts, not a prevalence count) (population)
IPCC AR6 — climate impacts are global · 2026-06-09
Headline scale
37,400,000,000 tonnes of CO2 emitted per year (fossil) (worsening)
Global Carbon Project: fossil CO2 emissions are still rising, even as the clean-energy share of new capacity climbs fast. · 2026-06-09
Market size
4,500,000,000,000 USD / year
IEA Net Zero Roadmap (2023 update) — required annual clean-energy investment by the early 2030s to stay on a 1.5C-consistent path, up from $1.8T invested in 2023 · 2026-08-20
Annual capital flow
1,500,000,000,000 USD/yr (rising)
Climate Policy Initiative — Global Landscape of Climate Finance 2024 · 2024-10-31
Expert prior
not yet sourced
Annual CO₂ emissions
38,598,580,000 t
Query: annual-co2-emissions · 2026-11-10
OpenAlex works, last 12 months
33,386 works
Query: climate adaptation · 2026-11-10
NIH RePORTER funding
165,123,745 USD
Query: climate change health (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
38 documents
Query: climate adaptation · 2026-11-10
USAspending awards
362 awards
Query: climate adaptation · 2026-11-10
SEC EDGAR Form D filings
210 filings
Query: climate · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
167,337 pageviews
Query: Global_warming · 2026-11-10

Open the problem

Site rank 16 · Energy · hard-tech

AI datacenter power

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

AI data centers now need more electricity than grids can supply.

What just became possible

not yet sourced

Companies working on this (0)

No sourced company is on file.

Open quest, not a real company

Acme AI datacenter power Co. (open quest, not a real company)

Problem: AI datacenter power. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: How much datacenter load will arrive is uncertain, and who pays for the upgrades is not settled. US DOE release on the LBNL 2024 United States Data Center Energy Usage Report

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 17,635 works Source
  • NIH RePORTER funding: 789,105,160 USD Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: not yet sourced
  • USAspending awards: 18 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 146,618 pageviews Source
  • Sourced companies on file: 0 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Engineering, Sales
  • Domains: Energy
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
8,200,000,000 humans (indirect exposure, not a direct affliction count) (indirect)
Indirect and low-confidence by design: global AI-driven productivity and service gains are gated on this specific power bottleneck, not a direct affliction count like a disease or poverty line. · 2026-04-24
Headline scale
2,300 GW stuck in US interconnection queues (worsening)
Quartz / Sightline Climate interconnection-queue tracking · 2026-08-20
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
17,635 works
Query: AI data center · 2026-11-10
NIH RePORTER funding
789,105,160 USD
Query: AI data center (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
18 awards
Query: AI data center · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
146,618 pageviews
Query: AI_data_center · 2026-11-10

Open the problem

Site rank 17 · Health · welfare

Diabetes

Sourced demand is listed on this quest. 8 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

IDF: 589 million adults aged 20–79 in 2024. WHO: 59% of adults aged 30+ were not on medication in 2022. Different groups and years.

What just became possible

Companies working on this (6)

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 8 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
589,000,000 adults aged 20–79 living with diabetes in 2024 (IDF). Not the WHO 30+ medication group. (prevalence)
IDF Diabetes Atlas, 11th edition, 2025 · 2026-09-11
Headline scale
830,000,000 people living with diabetes, all ages (WHO) (worsening)
WHO diabetes fact sheet. IDF projects 853 million adults by 2050, a 45 percent rise from 2024 · 2026-09-11
Market size
53,460,000,000 USD / year, GLP-1 class alone (2024), a floor for total diabetes medicine spend, which also includes insulin and older oral drugs
Precedence Research, GLP-1 drugs market 2024, via BioSpace · 2026-09-11
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
138,279 works
Query: diabetes · 2026-11-10
NIH RePORTER funding
3,128,058,768 USD
Query: diabetes (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
3,874 active trials
Query: Diabetes Mellitus · 2026-11-10
ClinicalTrials.gov industry sponsors
373 industry sponsors
Query: Diabetes Mellitus · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
5,798 awards
Query: diabetes · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
894,537 pageviews
Query: Diabetes · 2026-11-10

Open the problem

Site rank 18 · Health · welfare

Heart disease

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

The leading cause of death worldwide: 9,469,357 deaths from ischaemic heart disease in 2023.

What just became possible

not yet sourced

Companies working on this (0)

No sourced company is on file.

Who is building

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-20
OpenAlex works, last 12 months
5,785 works
Query: ischemic heart disease · 2026-11-20
NIH RePORTER funding
316,484,990 USD
Query: ischemic heart disease (FY2026) · 2026-11-20
ClinicalTrials.gov active trials
2,265 active trials
Query: Coronary Artery Disease · 2026-11-20
ClinicalTrials.gov industry sponsors
183 industry sponsors
Query: Coronary Artery Disease · 2026-11-20
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-20
USAspending awards
125 awards
Query: ischemic heart disease · 2026-11-20
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-20
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-20
Wikipedia pageviews (attention, not demand)
692,372 pageviews
Query: Coronary_artery_disease · 2026-11-20

Open the problem

Site rank 19 · Health · welfare

Organ banking

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

In 2024, 11,244 organs recovered for transplant in the United States were not transplanted. 109,817 people are on the US waiting list.

What just became possible

not yet sourced

Companies working on this (1)

Who is building

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
109,817 people on the US national transplant waiting list. The same list is on the organ-shortage problem and is not added to it. Not a global count. (population)
HRSA organdonor.gov, Organ Donation Statistics, date last reviewed August 2026. The page states 109,817 people on the national transplant waiting list. · 2026-11-20
Headline scale
11,244 US organs recovered for transplant but not transplanted (2024). 20.7 percent of organs recovered. The report does not say the cause was time. (worsening)
OPTN/SRTR 2024 Annual Data Report, deceased organ donation: 11,244 organs recovered for transplant but not transplanted in 2024, up from 10,085 in 2023. Nonuse was 20.7 percent of organs recovered in 2024. · 2026-11-20
Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
OpenAlex works, last 12 months
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
NIH RePORTER funding
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
USAspending awards
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
Wikipedia pageviews (attention, not demand)
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20

Open the problem

Site rank 20 · Science · progress

Scientific productivity

Sourced demand is listed on this quest. 22 named team rows on this site. 22 named capital rows on this site. Named team rows and named capital rows are the same count (22).

Open

Each research dollar buys less progress than it used to.

What just became possible

Companies working on this (9)

Open quest, not a real company

Acme Scientific productivity Co. (open quest, not a real company)

Problem: Scientific productivity. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: New ideas take more researchers and more training to find than they used to. Bloom, Jones, Van Reenen and Webb, Are Ideas Getting Harder to Find?, American Economic Review 2020

Demand numbers

  • Related deaths / yr: not yet sourced
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 246 works Source
  • NIH RePORTER funding: 0 USD Source
  • OpenAlex company affiliations: 0 companies Source
  • ClinicalTrials.gov active trials: not yet sourced
  • ClinicalTrials.gov industry sponsors: not yet sourced
  • Federal Register documents: 312 documents Source
  • USAspending awards: 1,273 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 47,853 pageviews Source
  • Sourced companies on file: 9 companies
  • Sourced founders: 11 founders
  • Sourced funders: 9 funders
  • Annual capital: 400,000,000 USD/yr Source

Founder fit

  • Skills: Engineering, Research
  • Domains: Science
  • Technologies: AI, Biotech
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

The gap

Sourced demand is listed on this quest. 22 named team rows on this site. 22 named capital rows on this site. Named team rows and named capital rows are the same count (22).

Humans affected
8,100,000,000 humans (indirect compound effect, not a direct affliction count) (indirect)
estimated, scientific productivity compounds across every domain · 2026-04-24
Headline scale
18 x more researchers needed to sustain Moore’s-law progress vs the 1970s (worsening)
Bloom, Jones, Van Reenen & Webb (2020), "Are Ideas Getting Harder to Find?" — research productivity is falling across many fields. · 2026-06-09
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
246 works
Query: metascience · 2026-11-10
NIH RePORTER funding
0 USD
Query: metascience (FY2026) · 2026-11-10
OpenAlex company affiliations
0 companies
Query: metascience · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
312 documents
Query: scientific integrity · 2026-11-10
USAspending awards
1,273 awards
Query: research infrastructure · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
47,853 pageviews
Query: Metascience · 2026-11-10

Open the problem

Site rank 21 · Health · welfare

The organ shortage

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

109,817 people are on the US transplant waiting list, and HRSA says 12 people die each day waiting. eGenesis reports five pig-kidney recipients.

What just became possible

not yet sourced

Companies working on this (1)

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 3 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
109,817 people on the US national transplant waiting list. The same list is on organ banking and is not added to it. Not a global waiting list. (population)
HRSA organdonor.gov, Organ Donation Statistics, date last reviewed August 2026. The page states 109,817 people on the national transplant waiting list. · 2026-11-20
Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
OpenAlex works, last 12 months
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
NIH RePORTER funding
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
USAspending awards
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
Wikipedia pageviews (attention, not demand)
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20

Open the problem

Site rank 22 · Health · welfare

Brain-computer interfaces

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

About 30,000 people in the United States are living with ALS. Seven people in a UK study have a Neuralink implant.

What just became possible

not yet sourced

Companies working on this (2)

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 4 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
30,000 people estimated to be living with ALS in the United States. CDC says about 30,000. Not a global count, and not spinal cord injury or stroke. (prevalence)
CDC National ALS Registry fact sheet, ALS: A Closer Look, last reviewed June 2024. The sheet says it is estimated that about 30,000 people are living with ALS. · 2026-11-20
Headline scale
not yet sourced
Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
OpenAlex works, last 12 months
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
NIH RePORTER funding
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
USAspending awards
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
Wikipedia pageviews (attention, not demand)
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20

Open the problem

Site rank 23 · Health · welfare

Artificial womb

Sourced demand is listed on this quest. 2 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

WHO: about 900,000 children died of preterm-birth complications in 2019. Those deaths stay on newborn survival.

What just became possible

not yet sourced

Companies working on this (1)

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 2 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
900,000 deaths of children from preterm-birth complications in 2019. An annual flow, not a census of extremely preterm babies. Counted inside newborn survival and not added again in the burden roll-up. (annual-deaths)
WHO preterm birth fact sheet, 10 May 2023: preterm birth complications caused approximately 900,000 deaths in 2019. · 2026-11-20
Headline scale
not yet sourced
Market size
not yet sourced
Annual capital flow
not yet sourced
Expert prior
not yet sourced
OpenAlex works, last 12 months
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
NIH RePORTER funding
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
USAspending awards
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20
Wikipedia pageviews (attention, not demand)
not yet sourced
The search term is registered. A live count was not stored in this pass, so no number was invented. · 2026-11-20

Open the problem

Site rank 24 · Governance · progress

Financial infrastructure

Sourced demand is listed on this quest. Named teams: not yet sourced. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

Moving money should be nearly free for everyone. It still is not.

What just became possible

not yet sourced

Companies working on this (0)

No sourced company is on file.

Who is building

not yet sourced

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. Named teams: not yet sourced. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
1,300,000,000 unbanked adults (prevalence)
World Bank Global Findex 2025 (account ownership reached 79% of adults, up from 74% in 2021) · 2026-08-22
Headline scale
not yet sourced
Market size
2,500,000,000,000 USD / year (global payments revenue)
McKinsey Global Payments Report 2025: $2.5T revenue on ~$2.0 quadrillion of value flows, forecast above $3T by 2029 · 2026-08-22
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
21,346 works
Query: payment system · 2026-11-10
NIH RePORTER funding
142,609,401 USD
Query: payment system (FY2026) · 2026-11-10
ClinicalTrials.gov active trials
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
ClinicalTrials.gov industry sponsors
not yet sourced
Not a clinical condition. No trial query was registered. · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
127 awards
Query: payment system · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
79,008 pageviews
Query: Payment_system · 2026-11-10

Open the problem

Site rank 25 · Health · welfare

Cancer

Sourced demand is listed on this quest. 9 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Open

The second-largest cause of death on Earth: 9.7 million deaths a year.

What just became possible

Intismeran Autogene plus Pembrolizumab for Resected Stage IIB to IV Melanoma

New England Journal of Medicine · 2026-11-11 · trial-result · tagged tractability

In a phase 3 double-blind trial, 1137 patients with completely resected high-risk cutaneous melanoma had recurrence-free survival at 24 months of 82.2% with the individualized neoantigen therapy intismeran plus pembrolizumab versus 70.0% with pembrolizumab alone, and distant-metastasis-free survival of 88.5% versus 80.2%.

Evolutionary dynamics in the years preceding acute myeloid leukaemia

Nature · 2026-11-11 · peer-reviewed · tagged tractability

Annual blood samples collected for up to a decade before acute myeloid leukaemia diagnosis show that the first driver mutations are typically acquired in the first few decades of life, and that later clones with multiple driver mutations and selective advantages up to 100-fold larger can sweep the blood decades before diagnosis, a window for early detection.

Blood-based RNA biomarker for the early detection of ovarian cancer

Nature Medicine · 2026-11-10 · peer-reviewed · tagged tractability

In serum extracellular vesicles from 506 individuals, the extracellular-vesicle RNA Tu-stroma discriminated the precursor lesion STIC from controls with AUC 0.99 versus 0.59 for CA125. Prospective evaluation is still required to validate diagnostic performance.

Companies working on this (5)

Open quest, not a real company

Acme Cancer Co. (open quest, not a real company)

Problem: Cancer. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Cancer trials are slow because few patients enroll and many trials never finish. HealthDay: enrollment in cancer treatment trials about 7% (Unger, JCO)

Demand numbers

  • Related deaths / yr: 9,700,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 373,950 works Source
  • NIH RePORTER funding: not yet sourced Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 33,901 active trials Source
  • ClinicalTrials.gov industry sponsors: 2,090 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 21,298 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 1,096,969 pageviews Source
  • Sourced companies on file: 5 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Open quest, not a real company

Acme Cancer Co. (open quest, not a real company)

Problem: Cancer. This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Gap it would fill: Poor accrual is the leading reason cancer trials stop early. PMC: premature termination in oncology trials

Demand numbers

  • Related deaths / yr: 9,700,000 deaths/yr Source
  • Burden feed: not yet sourced
  • OpenAlex works, last 12 months: 373,950 works Source
  • NIH RePORTER funding: not yet sourced Source
  • OpenAlex company affiliations: count capped Source
  • ClinicalTrials.gov active trials: 33,901 active trials Source
  • ClinicalTrials.gov industry sponsors: 2,090 industry sponsors Source
  • Federal Register documents: not yet sourced
  • USAspending awards: 21,298 awards Source
  • SEC EDGAR Form D filings: not yet sourced
  • openFDA current drug shortages: not yet sourced
  • Wikipedia pageviews (attention, not demand): 1,096,969 pageviews Source
  • Sourced companies on file: 5 companies
  • Sourced founders: 0 founders
  • Sourced funders: 0 funders
  • Annual capital: not yet sourced

Founder fit

  • Skills: Biology, Design, Sales, Research
  • Domains: Health
  • Technologies: not yet sourced
  • Places: not yet sourced
  • Networks: not yet sourced

Take this quest

Who is building

Named on the problem

Who funds it

not yet sourced

The gap

Sourced demand is listed on this quest. 9 named team rows on this site. Named capital: not yet sourced. The thinner side is not yet sourced.

Humans affected
20,000,000 new cancer diagnoses per year (2022). Annual incidence, not people living with cancer. (incidence)
IARC GLOBOCAN 2022, via UICC · 2026-09-11
Market size
252,000,000,000 USD / year, global spending on cancer medicines (2024); IQVIA projects $441B by 2029
IQVIA Institute, Global Oncology Trends 2025 · 2026-09-11
Annual capital flow
not yet sourced
Expert prior
not yet sourced
Burden feed
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
OpenAlex works, last 12 months
373,950 works
Query: cancer · 2026-11-10
ClinicalTrials.gov active trials
33,901 active trials
Query: Cancer · 2026-11-10
ClinicalTrials.gov industry sponsors
2,090 industry sponsors
Query: Cancer · 2026-11-10
Federal Register documents
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
USAspending awards
21,298 awards
Query: cancer · 2026-11-10
SEC EDGAR Form D filings
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
openFDA current drug shortages
not yet sourced
No query is registered for this problem. A query was not invented. · 2026-11-10
Wikipedia pageviews (attention, not demand)
1,096,969 pageviews
Query: Cancer · 2026-11-10

Open the problem